Author Archives: admin

Epigenetic editing was used to reduce the activity of a gene that affects cholesterol levels without changing the DNA sequence — and did so for an extended period, according to a study in mice by Cappelluti and colleagues. The study lays the … Continue reading

Posted in Uncategorized | Comments Off on Epigenetic editing cuts cholesterol in mice

T cells that are specific for B cells infected with Epstein–Barr virus (EBV) are enriched in the cerebrospinal fluid (CSF) of people with early multiple sclerosis (MS), according to new research. The finding adds to evidence that EBV has a role … Continue reading

Posted in Uncategorized | Comments Off on T cells implicate Epstein–Barr virus in multiple sclerosis pathogenesis

“HPV and Tobacco: Dangerous Lesions Author: Stéphanie Lavaud.     Date: February 23, 2024 PARIS — Cancer and tobacco are a dangerous combination. This adage holds particularly true for cervical cancer, which is induced by high-risk human papillomavirus(HPV). Julia Maruani, MD, a … Continue reading

Posted in Uncategorized | Comments Off on Tobacco, HPV and Cancer Links

Abstract BACKGROUND Food allergies are common and are associated with substantial morbidity; the only approved treatment is oral immunotherapy for peanut allergy. METHODS In this trial, we assessed whether omalizumab, a monoclonal anti-IgE antibody, would be effective and safe as … Continue reading

Posted in Uncategorized | Comments Off on New Treatment for Multiple Food Allergies

Significance In the midst of rapid globalization, the peaceful coexistence of cultures requires a deeper understanding of the forces that compel prosocial behavior and thwart xenophobia. Yet, the conditions promoting such outgroup-directed altruism have not been determined. Here we report … Continue reading

Posted in Uncategorized | Comments Off on Oxytocin-enforced norm compliance reduces xenophobic outgroup rejection

Abstract: A 30-year-old woman presented with rapidly progressive dementia 1 month after the coronavirus disease 2019 infection. Repeated CSF analysis showed extreme hypoglycorrhachia, while cultures, metagenomic next-generation sequencing, and cytopathology testing of CSF were negative. Laboratory investigations for possible etiologies revealed … Continue reading

Posted in Uncategorized | Comments Off on Rapidly Progressive Dementia and Extreme Hypoglycorrhachia after Covid-19: Case Study

  “Neurologic damage following acute viral infections may be attributed to an excessive immune response to the infection, according to a new study. Many viral infections that don’t directly infect the central nervous system (CNS) have been associated with severe … Continue reading

Posted in Uncategorized | Comments Off on Immune Response to Viruses May Be Responsible for Neurological Damage

  “COVID-19 can cause long-term problems with thinking, concentrating, and remembering. This condition is commonly known as “brain fog.” Brain fog after COVID-19 has been studied mostly by observing previously healthy people. In a small study supported by the National … Continue reading

Posted in Uncategorized | Comments Off on Rapid Progression of Dementia Following COVID-19

“Abstract: Three-dimensional printing technology, also called additive manufacturing technology, is used to prepare personalized 3D-printed drugs through computer-aided model design. In recent years, the use of 3D printing technology in the pharmaceutical field has become increasingly sophisticated. In addition to … Continue reading

Posted in Uncategorized | Comments Off on A Review of 3D Printing Technology in Pharmaceutics: Technology and Applications, Now and Future

This study explores the innovative production of personalized bilayer tablets, integrating two advanced manufacturing techniques: Droplet Deposition Modeling (DDM) and Injection Molding (IM). Unlike traditional methods limited to customizing dense bilayer medicines, our approach uses Additive Manufacturing (AM) to effectively … Continue reading

Posted in Uncategorized | Comments Off on 3D Medicine production: Tailoring drug release in bilayer tablets through droplet deposition modeling and injection molding